Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Calithera Biosciences, Inc. (CALA)  
$0.02 0.00 (0.00%) as of 4:30 Wed 4/24


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 97,237,000
Market Cap: 1.94(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.015 - $0.365
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Calithera Biosciences is a clinical-stage precision oncology biopharmaceutical company developing targeted therapies to redefine treatment for biomarker-specific patient populations. Co.'s product candidate, CB-280, is an oral inhibitor of arginase, developed for the treatment of cystic fibrosis. Co. has also identified CB-668, an orally administered inhibitor of the immune-suppressive enzyme IL4I1. An additional arginase inhibitor, INCB001158, was discovered by Co. and is being developed by Incyte Corporation for oncology and hematology indications. Co. has developed CB-708, a selective, orally-bioavailable small molecule inhibitor of CD73.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 121,333
Total Sell Value $0 $0 $0 $46,810
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 141
  Page 4 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sjogren Eric SR. VP, DRUG DISCOVERY   •       –      –    2018-04-03 4 OE $0.48 $8,069 D/D 16,810 42,818     -
   Molineaux Christopher SR. VP, DEVELOPMENT   •       –      –    2018-03-02 4 OE $2.64 $17,947 D/D 6,798 21,000     -
   Molineaux Susan PRESIDENT AND CEO   •       •      –    2018-03-02 4 OE $2.64 $71,259 D/D 26,992 44,860     -
   Wong Stephanie SR VP, FINANCE AND SECRETARY   •       –      –    2018-02-23 4 OE $2.64 $26,400 D/D 10,000 15,000     -
   Parlati Francesco VP, RESEARCH   •       –      –    2018-02-20 4/A OE $0.96 $4,891 D/D 5,095 28,455     -
   Parlati Francesco VP, RESEARCH   •       –      –    2018-02-20 4 OE $0.96 $4,891 D/D 5,095 20,488     -
   Molineaux Susan PRESIDENT AND CEO   •       •      –    2017-12-05 4 OE $0.96 $21,257 D/D 12,868 15,368     -
   Molineaux Christopher SR. VP, DEVELOPMENT   •       –      –    2017-12-05 4 OE $0.96 $13,370 D/D 9,202 11,702     -
   Gross Phillip 10% Owner   –       –       •   2017-09-28 4 S $15.50 $589,000 I/I (38,000) 3,546,873     -
   Gross Phillip 10% Owner   –       –       •   2017-09-27 4 S $15.59 $2,899,740 I/I (186,000) 3,584,873     -
   Gross Phillip 10% Owner   –       –       •   2017-09-26 4 S $15.68 $5,519,360 I/I (352,000) 3,770,873     -
   Orford Keith SR. VP, CLINICAL DEVELOPMENT   •       –      –    2017-07-17 4 AS $18.31 $38,823 D/D (2,120) 6,879     -
   Wong Stephanie VP, FINANCE AND SECRETARY   •       –      –    2017-07-17 4 AS $18.41 $65,385 I/I (3,552) 10,550     -
   Hecht Curtis SVP, BUS. & CORP. DEVELOPMENT   •       –      –    2017-07-06 4 AS $18.00 $12,600 D/D (700) 15,940     -
   Hecht Curtis SVP, BUS. & CORP. DEVELOPMENT   •       –      –    2017-05-19 4 AS $16.00 $10,400 D/D (650) 14,910     -
   Gross Phillip 10% Owner   –       –       •   2017-03-22 4 B $10.25 $4,999,991 I/I 487,804 4,122,873 1.5     -
   Molineaux Christopher SR. VP, DEVELOPMENT   •       –      –    2016-12-19 4 OE $0.96 $17,739 D/D 10,167 12,044     -
   Molineaux Susan PRESIDENT AND CEO   •       •      –    2016-12-19 4 OE $0.96 $47,309 D/D 21,933 23,810     -
   Gross Phillip 10% Owner   –       –       •   2016-11-16 4 B $3.15 $1,575,000 I/I 500,000 3,635,069 1.5     -
   Waddill William D. SR. VP & CFO   •       –      –    2016-09-29 4 D $0.00 $0 D/D (17,485) 17,485     -
   Jones Suzy Director   –       •      –    2016-08-09 3 IO $0.00 $0 D/D 0 7,197     -
   Hecht Curtis VP, BUS. & CORP. DEVELOPMENT   •       –      –    2016-08-08 4 A $0.00 $0 D/D 3,085 14,210     -
   Molineaux Susan PRESIDENT AND CEO   •       •      –    2016-07-20 4 OE $0.48 $53,218 D/D 29,385 31,885     -
   Molineaux Christopher SR. VP, DEVELOPMENT   •       –      –    2016-07-20 4 OE $0.96 $19,820 D/D 12,335 14,835     -
   Orford Keith SR. VP, CLINICAL DEVELOPMENTOf   •       –      –    2016-05-02 3 IO $0.00 $0 D/D 0 2,120     -
  141 Records found
  1  2  3  4  5  6   
  Page 4 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us